Then, the chi-square test was used to evaluate the correlations between EDEM1 expression and clinicopathologic features of breast cancer patients, including age, tumor stage, LN metastasis, distant metastasis, histologic grade, ER (estrogen receptor) status, PR (progesterone receptor) status, HER-2 status, and Ki67 expression. This evidence concerns the gene ERBB2 and neoplasm.